Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Eleven Biotherapeutics
4030
Eleven Biotherapeutics
Health Care
Technology
Biotechnology
Eleven Biotherapeutics is focused on developing innovative protein-basedtherapeutics to improve human health and treat diseases.
Suggest edits
Founded
2010
Raised
$63M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
AirXpanders
Vital Connect
GlycoMimetics
Ritter Pharmaceuticals, Inc.
Horizon Pharma plc
Intercept Pharmaceuticals
NeuroMetrix, Inc.
Uptake Medical
ENDOTRONIX
Immune Design
Alexa global traffic share
Overview
Funding
3
Acquisitions
1
Add info
Latest funding
Show all
$8,000,000
Post-IPO equity - 2017
$20,000,000
Post-IPO equity - 2014
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Acquisition
Seeking Alpha
,
businesswire
Eleven Biotherapeutics acquires Viventia Bio in all-stock deal
